Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 37 - Drugs for immunological or allergic disorders
Patents for A61P 37 - Drugs for immunological or allergic disorders (117,141)
03/2012
03/15/2012US20120064115 Recombinant virus-like particles encoded by multi-gene vector
03/15/2012US20120064114 Use of e. coli surface antigen 3 sequences for the export of heterologous antigens
03/15/2012US20120064109 Immunogenic composition and uses thereof
03/15/2012US20120064108 Glycoconjugate vaccines
03/15/2012US20120064107 Compositions and methods for treatment of autoimmune and other disease
03/15/2012US20120064106 Flagellin fusion proteins and use thereof to induce immune responses against pseudomonas aeruginosa
03/15/2012US20120064105 Engineered Type IV Pilin of Clostridium difficile
03/15/2012US20120064103 Combinations of meningococcal factor h binding protein and pneumococcal saccharide conjugates
03/15/2012US20120064102 Peptide inducing xage-1b-specific immune reaction and utilization of same
03/15/2012US20120064101 Compounds and Methods Useful for Detection and Treatment of Cancer
03/15/2012US20120064100 Biomarkers and uses thereof
03/15/2012US20120064099 Compounds that inhibit nfkb and bace1 activity
03/15/2012US20120064096 BTLA Antibodies and Uses Thereof
03/15/2012US20120064089 Anti-cxcl16 and anti-cxcr6 antibodies for the prevention and treatment of cancer and cancer cell migration
03/15/2012US20120064086 High concentration antibody and protein formulations
03/15/2012US20120064081 Anti-kir3d antibodies
03/15/2012US20120064080 Human LY6-Big Molecules and Methods of Use
03/15/2012US20120064073 Il-17 homologous polypeptides and therapeutic uses thereof
03/15/2012US20120064062 Inhibitors of bacterial plasminogen activators
03/15/2012US20120064060 Compound having s1p receptor binding potency and use thereof
03/15/2012US20120064051 Infant and young children feeding formula comprising probiotics for infants and young children
03/15/2012US20120064048 Treatment of reprogramming factor related diseases by inhibition of natural antisense transcript to a reprogramming factor
03/15/2012US20120064037 Methods For Treating Diseases and HCV Using Antibodies To Aminophospholipids
03/15/2012US20120064035 Vaccine immunotherapy
03/15/2012US20120064033 Modulation of regulatory t cells by human il-18
03/15/2012US20120064031 Cells, nucleic acid constructs, cells comprising said constructs and methods utilizing said cells in the treatment of diseases
03/15/2012US20120064025 Quinazolinone Modulators Of Nuclear Receptors
03/15/2012US20120064004 Isotopologues of thalidomide
03/15/2012US20120063998 Method for Treating Psoriatic Arthritis by Administering an Anti-IL-12 Antibody
03/15/2012US20120063996 Novel nimesulide compositions
03/15/2012US20120063994 Rtef-1 variants and uses thereof
03/15/2012US20120063993 Therapeutic and diagnostic conjugates for use with multispecific antibodies
03/15/2012CA2810858A1 Imidazo [1, 2] pyridazin compounds and compositions as trk inhibitors
03/15/2012CA2810489A1 Prostaglandin d synthase inhibitory piperidine compounds
03/14/2012EP2428222A2 Vaccine peptide combinations against cat allergy
03/14/2012EP2427217A1 Multi- valent adjuvant display
03/14/2012EP2202229B1 Novel preparation for external use
03/14/2012EP1636171B1 Amino-propanol derivatives as sphingosine-1-phosphate receptor modulators
03/14/2012EP1499729B9 Derivatives of the nf-kappab inducing enzyme, their preparation and use
03/14/2012EP1471895B2 Formulation for inhalation comprising a glucocorticoid and a beta 2-adrenoreceptor agonist
03/14/2012EP1455766B1 Thymosin alpha 1 peptide/polymer conjugates
03/14/2012EP1147104B1 Aromatic heterocyclic compounds as antiinflammatory agents
03/14/2012CN102378633A Immunologic adjuvant composition and use thereof
03/14/2012CN102373135A Mulberry leaf scented rice wine
03/14/2012CN102372779A Camel single domain antibody with allinase activity as well as preparation method and application thereof
03/14/2012CN102372713A Dual alanyl-aminopeptidase and dipeptidyl-peptidase iv inhibitors
03/14/2012CN102370977A Novel vaccine adjuvant and application
03/14/2012CN102370963A Traditional Chinese medicine for treating allergic colonitis
03/14/2012CN102370923A Health-care composition for enhancing immunity, and preparation method thereof
03/14/2012CN102370864A Medicament for treating eczema infection
03/14/2012CN102370761A Traditional Chinese medicine compound recipe used for preventing or resisting allergy, preparation method thereof, and application thereof
03/14/2012CN102370720A Desensitization paste for treating rhinitis
03/14/2012CN102370716A Health-preserving health-care medicine of gynostemma pentaphylla and multiflower knotweed root
03/14/2012CN102370713A Preparation method for momordin
03/14/2012CN102370695A Qinglongyi active extract, its preparation method and its application
03/14/2012CN102370660A Application of black-bone chicken blood to regulation of immunity
03/14/2012CN102370610A Anti-allergy medicine gel and preparation method thereof
03/14/2012CN102370395A Chinese medicinal health-care pillow and manufacturing method thereof
03/14/2012CN101843629B New application of icariin and epimedium flavone containing icariin
03/14/2012CN101318011B Pentapeptide nose spraying agent for thymus gland, preparation method and application thereof
03/14/2012CN101233225B Strain of turkey tail mushroom, extract from the same, and use of the same
03/14/2012CN101096359B Polyaryl substituted methane oxygen or silica radical guanidine compound and preparation method and usage thereof
03/13/2012US8133983 Agonistic binding molecules to the human OX40 receptor
03/13/2012US8133972 IgE antigenic peptides
03/13/2012US8133873 Recombinant chemokine-antigen vaccine
03/13/2012US8133728 Ex-vivo priming for generating cytotoxic T lymphocytes specific for non-tumor antigens to treat autoimmune and allergic disease
03/13/2012US8133726 Ex-vivo priming for generating cytotoxic T lymphocytes specific for non-tumor antigens to treat autoimmune and allergic disease
03/13/2012US8133515 Alkynes and methods of reacting alkynes with 1,3-dipole-functional compounds
03/13/2012CA2643097C Amine derivatives
03/13/2012CA2515574C Aminophosphonic acid derivative, salt thereof, and modulator of s1p receptor
03/13/2012CA2480468C Fredericamycin derivatives
03/13/2012CA2459811C Modified peptides and their use for the treatment of autoimmune diseases
03/13/2012CA2457015C Method for inducing selectively suppressed immune response
03/13/2012CA2442854C Hsa-free formulations of interferon-beta
03/13/2012CA2402191C Use of insulin for the treatment of cartilagenous disorders
03/13/2012CA2361806C Substituted 1-oxo- and 1,3-dioxoisoindolines and their use in pharmaceutical compositions for reducing inflammatory cytokine levels
03/13/2012CA2356779C Cytokine receptor chain
03/13/2012CA2238080C A novel haemopoietin receptor and genetic sequences encoding same
03/12/2012DE20321890U1 Impfstoffzusammensetzung The vaccine composition
03/12/2012DE20321889U1 Impfstoffzusammensetzung The vaccine composition
03/08/2012WO2012030948A1 Quinazoline compounds and methods of use thereof
03/08/2012WO2012030894A1 Thienopyridine and thienopyrimidine compounds and methods of use thereof
03/08/2012WO2012030745A1 MULTIVITAMIN TARGETING OF RNAi THERAPEUTICS
03/08/2012WO2012030137A2 Pharmaceutical composition for preventing or treating inflammatory diseases, allergic diseases or asthma, containing diospyros blancoi a. dc. extract as active ingredient
03/08/2012WO2012029942A1 Cyclic amide derivative
03/08/2012WO2012029367A1 Intestine immunomodulator
03/08/2012WO2012029348A1 Granules containing bitter drug and orally disintegrating tablet
03/08/2012WO2012028106A1 Deuterium-enriched heterocyclic compounds as kinase inhibitors
03/08/2012WO2012028100A1 Novel compounds
03/08/2012WO2012027960A1 Quinazoline derivatives substituted by aniline, preparation method and use thereof
03/08/2012WO2012027850A1 Peptide containing multiple n-linked glycosylation sequons
03/08/2012WO2011130434A3 Antibodies that bind human cd27 and uses thereof
03/08/2012WO2011126264A3 Method for increasing activity in human stem cell
03/08/2012US20120060230 Methods and compositions for modification of a hla locus
03/08/2012US20120060229 Method For Characterising The Biological Activity Of Helminth Eggs, In Particular Trichuris Eggs
03/08/2012US20120059462 Methods for reducing or preventing transplant rejection in the eye and intraocular implants for use therefor
03/08/2012US20120059358 Dna vaccines encoding heat shock proteins
03/08/2012US20120059055 N,n-disubstituted aminoalkylbiphenyl antagonists of prostaglandin d2 receptors
03/08/2012US20120059046 Inhibition of map4k4 through rnai
03/08/2012US20120059043 Therapeutic and diagnostic strategies
1 ... 141 142 143 144 145 146 147 148 149 150 151 152 153 154 155 156 157 158 159 160 161 ... 1172